Hepatitis C Core-Antigen Testing from Dried Blood Spots

Mia J Biondi1,2,3, Marjolein van Tilborg4,5, David Smookler6,7

  • 1Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada. mia.biondi@mail.mcgill.ca.

Viruses
|September 7, 2019
PubMed

Insights

Dried blood spot (DBS) testing for hepatitis C virus (HCV) antibodies and core antigen shows high accuracy across various temperatures. This method offers a viable alternative to HCV RNA testing, improving accessibility and reducing costs for HCV screening.

Area of Science:

  • Virology
  • Immunology
  • Diagnostic Medicine

Background:

  • Hepatitis C virus (HCV) screening requires accessible and cost-effective diagnostic methods.
  • Dried blood spot (DBS) collection offers a promising alternative for sample collection and transportation.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of HCV antibody (HCV-Ab) and HCV core antigen (core-Ag) testing using DBS cards under various temperature conditions.
  • To compare the performance of DBS testing with venous and capillary blood samples.

Main Methods:

  • Blood samples from 68 chronic HCV patients were collected on DBS cards and stored for one week at temperatures ranging from -80 °C to 37 °C.
  • Eluted samples were tested for HCV-Ab and core-Ag.
  • A head-to-head comparison of venous vs. capillary samples and single vs. double DBS spots was performed.

Main Results:

  • High sensitivity for HCV-Ab detection was observed across all tested temperatures.
  • Core-Ag sensitivity remained high (91-94%) across different storage temperatures.
  • No significant difference in core-Ag sensitivity was found between venous and capillary samples, with improved sensitivity using two DBS spots.

Conclusions:

  • HCV-Ab and core-Ag testing using DBS cards demonstrates high diagnostic accuracy and stability under various temperature conditions.
  • DBS testing is a reliable alternative to HCV RNA testing, particularly in settings where accessibility and cost are considerations.
  • Further validation supports the use of DBS cards for expanded HCV screening programs.

Related Concept Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

The preparing and processing of dried blood spots (DBS) for their final analysis are still poorly standardized for most diagnostic applications. To overcome this shortcoming, a comprehensive step-by-step protocol is suggested and subsequently evaluated with regard to its effectiveness for detecting markers of viral...
41.5K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Here we describe a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay to quantify the immunosuppressant tacrolimus in dried blood spots using a simple manual protein precipitation step and online column...
17.4K
Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers08:44

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers

This protocol describes a simple and useful method to store peripheral blood and serum/plasma for downstream analyses such as single nucleotide polymorphism (SNP) evaluation and ELISA...
10.9K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Biomarkers are directly-measured biological indicators of disease or health. In population and social sciences, biomarkers need to be easy to obtain, transport, and analyze. Dried Blood Spot (DBS) collection meets this need, can be collected in the field with high response rates and analyzed for a variety of...
37.2K
Suppressing Hepatitis B Virus Replication Using Viral Antigen-Specific T Cells02:50

Suppressing Hepatitis B Virus Replication Using Viral Antigen-Specific T Cells

The video demonstrates an assay using human induced pluripotent stem cell (iPSC)-derived CD8+ T cells to inhibit hepatitis B virus (HBV) replication in mice. These T cells, engineered with HBV-specific receptors, are transferred into transgenic mice. Replication-competent HBV genome plasmids are then injected directly into the liver, enabling viral DNA uptake. Once viral antigens are expressed and presented by hybrid MHC-I molecules, the engineered T cells recognize and bind to these complexes.
590
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

The cell membrane modification of red blood cells (RBCs) with hyperbranched polyglycerol (HPG) is presented. Modified RBCs were characterized by aqueous two phase partitioning, osmotic fragility and complement mediated lysis. The camouflage of surface proteins and antigens was evaluated using the flow cytometry and Micro Typing System (MTS) blood phenotyping...
18.5K